nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Angiotensin I–converting enzyme insertion/insertion genotype as a genetic risk factor for cardiovascular disease
|
Ogimoto, Akiyoshi |
|
2005 |
150 |
1 |
p. e1- 1 p. |
artikel |
2 |
A review of the oral direct thrombin inhibitor ximelagatran
|
Mohapatra, Robert |
|
2005 |
150 |
1 |
p. 19-26 8 p. |
artikel |
3 |
Assessing prognosis in heart failure: Is hepatocyte growth factor the next B-type natriuretic peptide?
|
Katz, Jason N. |
|
2005 |
150 |
1 |
p. 1-3 3 p. |
artikel |
4 |
Azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome
|
Gabrielli, Maurizio |
|
2005 |
150 |
1 |
p. e9- 1 p. |
artikel |
5 |
Cereal fiber and whole-grain intake are associated with reduced progression of coronary-artery atherosclerosis in postmenopausal women with coronary artery disease
|
Erkkilä, Arja T. |
|
2005 |
150 |
1 |
p. 94-101 8 p. |
artikel |
6 |
Comparison of losartan and captopril on heart failure–related outcomes and symptoms from the losartan heart failure survival study (ELITE II)
|
Konstam, Marvin A. |
|
2005 |
150 |
1 |
p. 123-131 9 p. |
artikel |
7 |
Correction
|
|
|
2005 |
150 |
1 |
p. 143- 1 p. |
artikel |
8 |
Depressed autonomic nervous system function in African Americans and individuals of lower social class: A potential mechanism of race- and class-related disparities in health outcomes
|
Lampert, Rachel |
|
2005 |
150 |
1 |
p. 153-160 8 p. |
artikel |
9 |
Depression and ischemic heart disease: What have we learned so far and what must we do in the future?
|
Jiang, Wei |
|
2005 |
150 |
1 |
p. 54-78 25 p. |
artikel |
10 |
Depressive symptoms and inflammation among heart failure patients
|
Ferketich, Amy K. |
|
2005 |
150 |
1 |
p. 132-136 5 p. |
artikel |
11 |
Distal embolization during primary angioplasty: Histopathologic features and predictability
|
Limbruno, Ugo |
|
2005 |
150 |
1 |
p. 102-108 7 p. |
artikel |
12 |
Do stents reduce mortality compared with balloon angioplasty? A critical review of all the evidence
|
Al Suwaidi, Jassim |
|
2005 |
150 |
1 |
p. 7-10 4 p. |
artikel |
13 |
Editorial Board
|
|
|
2005 |
150 |
1 |
p. A5- 1 p. |
artikel |
14 |
Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: Results from the prematurely terminated ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial
|
|
|
2005 |
150 |
1 |
p. 116-122 7 p. |
artikel |
15 |
Improved long-term survival associated with stent deployment during percutaneous coronary interventions: Results from a registry of 3399 patients
|
Muhlestein, Joseph B. |
|
2005 |
150 |
1 |
p. 182-187 6 p. |
artikel |
16 |
Inflammation and coronary artery disease
|
Tiong, Alice Y. |
|
2005 |
150 |
1 |
p. 11-18 8 p. |
artikel |
17 |
Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery disease
|
Marroquin, Oscar C. |
|
2005 |
150 |
1 |
p. 109-115 7 p. |
artikel |
18 |
Information for authors
|
|
|
2005 |
150 |
1 |
p. A6-A7 nvt p. |
artikel |
19 |
Information for readers
|
|
|
2005 |
150 |
1 |
p. A8- 1 p. |
artikel |
20 |
Is it time to prescribe statins to patients with calcified aortic stenosis?
|
Rashidi, Arash |
|
2005 |
150 |
1 |
p. 41-45 5 p. |
artikel |
21 |
Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): Immediate and long-term results
|
Rodriguez, Alfredo E. |
|
2005 |
150 |
1 |
p. 188- 1 p. |
artikel |
22 |
Left ventricular diastolic function in normotensive subjects 2 months after acute myocardial infarction is related to glucose intolerance
|
Salmasi, Abdul-Majeed |
|
2005 |
150 |
1 |
p. 168-174 7 p. |
artikel |
23 |
Management of risk in peripheral artery disease: Recent therapeutic advances
|
Hackam, Daniel G. |
|
2005 |
150 |
1 |
p. 35-40 6 p. |
artikel |
24 |
[No title]
|
Lim, Michael J. |
|
2005 |
150 |
1 |
p. e13- 1 p. |
artikel |
25 |
[No title]
|
|
|
2005 |
150 |
1 |
p. 53- 1 p. |
artikel |
26 |
Percutaneous coronary intervention–induced emboli during primary PCI for STEMI: Too little, too much, or too late?
|
Kuntz, Richard E. |
|
2005 |
150 |
1 |
p. 4-6 3 p. |
artikel |
27 |
Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure
|
Lamblin, Nicolas |
|
2005 |
150 |
1 |
p. 137-143 7 p. |
artikel |
28 |
Prognostic value of electrocardiographic criteria for left ventricular hypertrophy
|
Hsieh, Bill P. |
|
2005 |
150 |
1 |
p. 161-167 7 p. |
artikel |
29 |
Randomized comparison of anterolateral versus anteroposterior electrode position for biphasic external cardioversion of atrial fibrillation
|
Siaplaouras, Stephanos |
|
2005 |
150 |
1 |
p. 150-152 3 p. |
artikel |
30 |
Relationships among exercise capacity, hypertrophy, and left ventricular diastolic function in nonobstructive hypertrophic cardiomyopathy
|
Matsumoto, Afonso Y. |
|
2005 |
150 |
1 |
p. 144-149 6 p. |
artikel |
31 |
Reply to Al-Shaer, Is atorvastatin more appropriate to use in combination with niacin than simvastatin in patients with the metabolic syndrome? (Am Heart J 2005;149:e17.)
|
Milionis, Haralampos J. |
|
2005 |
150 |
1 |
p. e7- 1 p. |
artikel |
32 |
Reply to Gasbarrini
|
Hillis, Graham |
|
2005 |
150 |
1 |
p. e11- 1 p. |
artikel |
33 |
Reply to Ogimoto
|
Chou, Hsiang-Tai |
|
2005 |
150 |
1 |
p. e3- 1 p. |
artikel |
34 |
Reply to Ogimoto, Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy (Am Heart J 2005;149:e19.)
|
Zaman, Azfar G. |
|
2005 |
150 |
1 |
p. e5- 1 p. |
artikel |
35 |
Table of Contents
|
|
|
2005 |
150 |
1 |
p. A1-A4 nvt p. |
artikel |
36 |
Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: Results of a randomized trial
|
Ohman, E. Magnus |
|
2005 |
150 |
1 |
p. 79-88 10 p. |
artikel |
37 |
Tezosentan in patients with acute heart failure: Design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS)
|
Teerlink, John R. |
|
2005 |
150 |
1 |
p. 46-53 8 p. |
artikel |
38 |
The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: An evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients
|
Seshadri, Niranjan |
|
2005 |
150 |
1 |
p. 27-34 8 p. |
artikel |
39 |
The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial
|
Zhang, Zefeng |
|
2005 |
150 |
1 |
p. 175-181 7 p. |
artikel |
40 |
The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: Insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial
|
Brener, Sorin J. |
|
2005 |
150 |
1 |
p. 89-93 5 p. |
artikel |
41 |
Treatment with granulocyte colony–stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction
|
Kuethe, Friedhelm |
|
2005 |
150 |
1 |
p. 115- 1 p. |
artikel |